Drugs Approved for Lung Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for lung cancer. The list includes generic and brand names. This page also lists common drug combinations used in lung cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in lung cancer that are not listed here.
Drugs Approved for Non-Small Cell Lung Cancer
- Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
- Adagrasib
- Afatinib Dimaleate
- Afinitor (Everolimus)
Afinitor Disperz (Everolimus) - Alecensa (Alectinib)
- Alectinib
- Alimta (Pemetrexed Disodium)
- Alunbrig (Brigatinib)
- Alymsys (Bevacizumab)
- Amivantamab-vmjw
- Atezolizumab
- Augtyro (Repotrectinib)
- Avastin (Bevacizumab)
- Bevacizumab
- Binimetinib
- Braftovi (Encorafenib)
- Brigatinib
- Capmatinib Hydrochloride
- Cemiplimab-rwlc
- Ceritinib
- Crizotinib
- Cyramza (Ramucirumab)
- Dabrafenib Mesylate
- Dacomitinib
- Docetaxel
- Doxorubicin Hydrochloride
- Durvalumab
- Encorafenib
- Enhertu (Fam-Trastuzumab Deruxtecan-nxki)
- Entrectinib
- Erlotinib Hydrochloride
- Everolimus
- Fam-Trastuzumab Deruxtecan-nxki
- Gavreto (Pralsetinib)
- Gefitinib
- Gilotrif (Afatinib Dimaleate)
- Gemcitabine Hydrochloride
- Gemzar (Gemcitabine Hydrochloride)
- Imfinzi (Durvalumab)
- Imjudo (Tremelimumab-actl)
- Infugem (Gemcitabine Hydrochloride)
- Ipilimumab
- Iressa (Gefitinib)
- Keytruda (Pembrolizumab)
- Krazati (Adagrasib)
- Lazcluze (Lazertinib Mesylate Hydrate)
- Lazertinib Mesylate Hydrate
- Libtayo (Cemiplimab-rwlc)
- Lorbrena (Lorlatinib)
- Lorlatinib
- Lumakras (Sotorasib)
- Mekinist (Trametinib Dimethyl Sulfoxide)
- Mektovi (Binimetinib)
- Methotrexate Sodium
- Mvasi (Bevacizumab)
- Necitumumab
- Nivolumab
- Opdivo (Nivolumab)
- Osimertinib Mesylate
- Paclitaxel
- Paclitaxel Albumin-stabilized Nanoparticle Formulation
- Pembrolizumab
- Pemetrexed Disodium
- Portrazza (Necitumumab)
- Pralsetinib
- Ramucirumab
- Repotrectinib
- Retevmo (Selpercatinib)
- Rozlytrek (Entrectinib)
- Rybrevant (Amivantamab-vmjw)
- Selpercatinib
- Sotorasib
- Tabrecta (Capmatinib Hydrochloride)
- Tafinlar (Dabrafenib Mesylate)
- Tagrisso (Osimertinib Mesylate)
- Tarceva (Erlotinib Hydrochloride)
- Taxotere (Docetaxel)
- Tecentriq (Atezolizumab)
- Tepmetko (Tepotinib Hydrochloride)
- Tepotinib Hydrochloride
- Trametinib Dimethyl Sulfoxide
- Tremelimumab-actl
- Trexall (Methotrexate Sodium)
- Vizimpro (Dacomitinib)
- Vinorelbine Tartrate
- Xalkori (Crizotinib)
- Yervoy (Ipilimumab)
- Zirabev (Bevacizumab)
- Zykadia (Ceritinib)
Drug Combinations Used to Treat Non-Small Cell Lung Cancer
Drugs Approved for Small Cell Lung Cancer
- Afinitor (Everolimus)
- Atezolizumab
- Doxorubicin Hydrochloride
- Durvalumab
- Etopophos (Etoposide Phosphate)
- Etoposide
- Etoposide Phosphate
- Everolimus
- Hycamtin (Topotecan Hydrochloride)
- Imdelltra (Tarlatamab-dlle)
- Imfinzi (Durvalumab)
- Lurbinectedin
- Methotrexate Sodium
- Nivolumab
- Opdivo (Nivolumab)
- Tarlatamab-dlle
- Tecentriq (Atezolizumab)
- Topotecan Hydrochloride
- Trexall (Methotrexate Sodium)
- Zepzelca (Lurbinectedin)